Novalis Biotech aims for January second close for new €25m fund
Novalis Biotech Incubation, a Belgian seed-stage biotech investor, is fundraising for a second, €25m investment vehicle, according to co-founder and managing director Jan Van den Berghe.
More on Funds
MTIP holds USD 250m final close for second fund
Health technology firm has made five deals from the fund and expects to back 10 companies in total
Speedinvest launches EUR 80m Climate & Industry Opportunity fund
Fund is intended to back the VC's existing industrial and climate technology startups
Supernova Capital aiming to raise EUR 250m by end of 2022
VC is also considering launching a new fund, Supernova 3, by Q1 2023
Partech closes second growth fund on EUR 650m
Second vehicle is significantly larger than its predecessor, Partech Growth I, which raised EUR 400m in 2015
Latest News
Permira in USD 5.8bn Mimecast take-private
Announcement follows a series of discussions with potential strategic and financial investors
Triton to buy Clinigen in GBP 1.2bn deal
Board of the UK-based listed pharmaceuticals company has agreed to the offer
Felix hires two new partners
Venture capital firm Felix Capital appoints Susan Lin and Julien Codorniou as its new partners
Inflexion taps Harris Williams for upcoming Alcumus exit
Private equity suitors could preempt the auction given the popularity of the space